November 7, 2016 PRINT PDF
What Evidence Do We Need for Biomarker Qualification?
226th ENMC International Workshop: Towards Validated and Qualified Biomarkers for Therapy Development for Duchenne Muscular Dystrophy
miR-122 An Exploratory Biomarker of Liver Injury: An Industry Perspective on the State of the Science and Experiences Pre-Clinically and Clinically
Critical Path Institute Launches Type 1 Diabetes Consortium
Biomarker Qualification: Collaboration, Strategy, and Implementation